Bayko

Type: Company
Name: Bayko
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Every Third Bulgarian Tourist to Spend September Holidays in Greece

Many Bulgarians will spend the long weekend including September 22, Bulgarian Independence Day, in one of the neighboring countries.Every third tourist who will travel abroad for the holidays chooses to go to Greece , according to Bayko Bajkov, head of ... [Published Sofia News Agency - Sep 16 2014]
Entities: Greece, Boyko Borisov, Bayko
First reported Sep 09 2014 - Updated Sep 09 2014 - 1 reports

UPDATE: JMP Securities Reiterates On Hyperion Therapeutics Inc As Diabetes Program Is Discarded

In a report published Tuesday, JMP Securities analyst Liisa A. Bayko reiterated a Market Outperform rating on Hyperion Therapeutics Inc (NASDAQ: HPTX), but lowered the price target from $40.00 to $35.00.In the report, JMP Securities noted, “Following ... [Published Benzinga.com - Sep 09 2014]
First reported Sep 04 2014 - Updated Sep 04 2014 - 1 reports

Bulgaria's Tourism Sector Expects 10% Decline in 2014

The Association of Bulgarian Tour Operators expects over 10% tourism decline this year, mainly due to the weak summer season and the lack of advertising.The number of tourists from the Netherlands has dropped by 30% this summer, and the number of Germans ... [Published Sofia News Agency - Sep 04 2014]
First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Historic home with modern-age tweaks

WHEN Hallcroft was built in 1908, Bradford was a city at the height of its prosperity – and the coal merchant who commissioned this imposing house with five/six bedrooms was determined that it should be the last word in modernity. So the ceilings are ... [Published Telegraph and Argus - Sep 01 2014]
First reported Aug 27 2014 - Updated Aug 28 2014 - 1 reports

Roche, InterMune a Strategic Play in Midst of Inversions

NEW YORK (The Deal) -- In 2003, Foster City, Calif.'s Gilead Sciences apurchased Durham, N.C.'s Triangle Pharmaceuticals for $464 million. Daniel Welch, CEO of Triangle at the time, was a key player in the transaction.Soon after his gig was up at Triangle, ... [Published The Street Latest - Aug 27 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

Roche paying $8.3 billion for InterMune and its ‘breakthrough’ respiratory drug

Roche Holding agreed to buy U.S. biotech company InterMune for $8.3 billion cash, the company announced Monday .Roche will pay $74 a share, representing a 38% premium over InterMune’s ITMN closing price on Friday. The deal has been approved by ... [Published Fortune - Aug 25 2014]
First reported Aug 24 2014 - Updated Aug 24 2014 - 1 reports

Greencastle-Antrim School District classroom/homeroom listings NOW ONLINE

Kindergarten Olivia Shew Room 101 Braedon Bowers, Owen Brooks, Olivia Carbaugh, Jayla Dobbins, Nathan Gray, Callista Hade, Alexis Harbaugh, Wyatt Hull, Evane Hunter, Brysen Lehman, Carter Lutz, Blaine Martin, Braylynn Mills, Ginger Moore, Alyssa Mowen, ... [Published Echo-Pilot - Aug 24 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

InterMune Wild Ride Set to Pay Off With Drug: Real M

The 14-year roller-coaster ride for InterMune Inc. (ITMN) shareholders may finally be coming to an end.The stock soared above $50 a handful of times since goingpublic in 2000, and fell below $10 just as often as InterMuneworked on developing the first ... [Published Bloomberg - Aug 14 2014]
First reported Jun 27 2014 - Updated Jun 27 2014 - 1 reports

Honor Roll: Eastlake North High School, Fourth quarter 2013-2014

Eastlake North High SchoolWilloughby-Eastlake City School DistrictFourth Quarter 2013-2014Principals ListNinth grade: Cameron Judith Barnes, David Michael Bayes, Hans Josiah Bogenrief, Jenna McKenzie Borthwick, Joseph Martin Chinchar, Francis Marie Collins, ... [Published News-Herald - Jun 27 2014]
First reported May 06 2014 - Updated May 06 2014 - 1 reports

Vertex Pharmaceuticals, Inc.'s (VRTX) CEO Jeffrey Leiden on Q1 2014 Earnings - Call Transcript

Vertex Pharmaceuticals, Inc. (VRTX) Q1 2014 Earnings Call Corrected Transcript: 01-May-2014PARTICIPANTS Corporate ParticipantsMichael Partridge - Vice President-Investor Relations, Vertex Pharmaceuticals, Inc.Jeffrey Leiden - Chairman, President & Chief ... [Published The Street Latest - May 06 2014]

Quotes

"Recall, Hyperion had acquired Israel-based Andromeda Biotech in June for the DiaPep277 asset. While the finding is unfortunate, there is limited impact to our model given the relatively modest assumptions we have had for the program, and feedback from investors in recent months suggested a lack of confidence in its prospects. As a result of this news, we bring our price target down to $35 based on a risk-adjusted discounted cash flow analysis, and we view Monday's weakness in the stock as a buying opportunity ahead of the company's upcoming analyst day on September 30, where we anticipate an update on the clinical development plan for its only product, Ravicti, in hepatic encephalopathy (HE), and we are hoping for good news that the long-awaited Phase 3 study can commence by 1Q15.”"
"Our forecast is that there will be a decrease of over 10% which is mainly due to the decline in summer tourism " he said
"We believe this is a good strategic fit for Roche" Liisa Bayko, biotechnology analyst at JMP Securities Inc., who followed InterMune, told The Deal in an interview

More Content

All (13) | News (13) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Every Third Bulgarian Tourist to Spend Septembe... [Published Sofia News Agency - Sep 16 2014]
UPDATE: JMP Securities Reiterates On Hyperion T... [Published Benzinga.com - Sep 09 2014]
Bulgaria's Tourism Sector Expects 10% Decline i... [Published Sofia News Agency - Sep 04 2014]
Historic home with modern-age tweaks [Published Telegraph and Argus - Sep 01 2014]
Roche, InterMune a Strategic Play in Midst of I... [Published The Street Latest - Aug 27 2014]
Roche paying $8.3 billion for InterMune and its... [Published Fortune - Aug 25 2014]
Greencastle-Antrim School District classroom/ho... [Published Echo-Pilot - Aug 24 2014]
InterMune Wild Ride Set to Pay Off With Drug: R... [Published Bloomberg - Aug 14 2014]
Honor Roll: Eastlake North High School, Fourth ... [Published News-Herald - Jun 27 2014]
Vertex Pharmaceuticals, Inc.'s (VRTX) CEO Jeffr... [Published The Street Latest - May 06 2014]
Playing with Lego helps girls build their minds... [Published Taipei Times Online - Jan 14 2014]
Honor Roll: Willowick Middle School, First quar... [Published News-Herald - Dec 12 2013]
Honor Roll: Willoughby Middle School: First qua... [Published News-Herald - Dec 12 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.